Paul R. Schimmel

Biography

Prior to his appointment to TSRI's faculty in 1997, Schimmel was the John D. and Catherine T. MacArthur Professor of Biochemistry and Biophysics at Massachusetts Institute of Technology. A member of the National Academy of Sciences, he is the author or co-author of many scientific papers and of a widely used three-volume textbook on biophysical chemistry. He was a recipient of the Alfred P. Sloan Fellowship, the American Chemical Society's Pfizer Award in Enzyme Chemistry, and was elected to membership in the American Academy of Arts and Sciences. He has been active in many scientific and academic organizations and committees, including service as Chairman of the Division of Biological Chemistry of the American Chemical Society and as an editorial board member of ten different scientific journals. Having a longstanding interest in the applications of basic biomedical research to human health, Dr. Schimmel holds several patents and is a co-founder of four biotechnology companies including Alkermes, Cubist, and Repligen. These companies are developing new therapies for human diseases and disorders. He is a graduate of Ohio Wesleyan University and holds a Ph.D. from Massachusetts Institute of Technology.

Research Interest

Nanoscience and Nanotechnology